Sign in to view content

Impact of Race on Vision Outcomes in RanibizumabTreated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trial

M. Ali Khan, MD, FACS, FASRS

Video
Published 2021

Related

Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2022
Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology
Matthew P. Ohr, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more